Role of iron and ferritin in TNFα-induced apoptosis in HeLa cells  by Cozzi, Anna et al.
Role of iron and ferritin in TNFK-induced apoptosis in HeLa cells
Anna Cozzia, Sonia Levia, Barbara Corsia, Paolo Santambrogioa, Alessandro Campanellaa,
Gianmario Gerardib, Paolo Arosiob;
aDibit, Department of Biological and Technological Research, IRCCS H. San Ra¡aele, Milano, Italy
bDepartment M.T. and Biomedical Technologies, University of Brescia, Via Valsabbina 19, 25125 Brescia, Italy
Received 7 January 2003; revised 24 January 2003; accepted 24 January 2003
First published online 7 February 2003
Edited by Barry Halliwell
Abstract We found that tumor necrosis factor K (TNFK)-in-
duced apoptosis in HeLa cells was accompanied by a V2-fold
increase in H- and L-ferritin and a decrease in transferrin re-
ceptor, two indices of increased iron availability. Iron supple-
mentation and overexpression of H-ferritin or its mutant with an
inactivated ferroxidase center reduced by about V50% the
number of apoptotic cells after TNFK-treatment, while overex-
pression of L-ferritin was ine¡ective. The data indicate that
H-ferritin has an anti-apoptotic activity unrelated to its ferrox-
idase activity and to its capacity to modify cellular iron metab-
olism.
( 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Iron is an essential element for the synthesis of enzymes
that are central to respiration, DNA synthesis and detoxi¢ca-
tion, but when in excess it is toxic to cells and parenchymal
tissues [1,2]. The mechanism of its toxicity has not been fully
clari¢ed and it is probably related to the easy oxidation that
releases a single electron with the production of damaging
reactive oxygen species molecules, as it occurs in the Fenton
reaction. Because of this property, iron is considered a pro-
oxidant agent that participates in the damage of membrane,
proteins and nucleic acids. Many oxidant agents are known to
induce cell death and apoptosis [3,4], but curiously, we are not
aware of reports showing that iron excess does it. On the
contrary, iron supplementation to cells was found to reduce
nitric oxide (NO)-induced apoptosis, an e¡ect that was attrib-
uted to the scavenging capacity of the metal on the NO [5,6].
In addition, cell treatment with iron chelators, which are ex-
pected to reduce iron availability, induce apoptosis in HeLa
and cancer cells through mechanisms that seem to involve
mitochondrial activation [7^9]. Thus, iron deprivation rather
than abundance seems to activate apoptotic pathways. Other
evidence that iron can be protective to cells comes from the
demonstration that exposure of cells to the pro-oxidant heme-
iron plus hydrogen peroxide protects cells from a following
oxidative insult [10,11]. Also upregulation of heme oxygenase
in epithelial cells was shown to be protective from oxidative
insults, and exert anti-apoptotic e¡ects [12^14]. One of the
products of this enzyme is the iron liberated from heme,
and this was thought to contribute to the protective e¡ect
together with CO and biliverdin [13]. The protective role of
iron may be secondary to the iron-induced ferritin upregula-
tion, which in turn would sequester iron and reduce its pro-
oxidant activity. However, ferritin expression is so tightly
regulated by iron that it is di⁄cult to distinguish between
the two. In addition, ferritin is composed of two subunit
types: the H- and L-chains which are similarly regulated by
iron, although they have distinctive functional activities : the
H-chain has ferroxidase activity and readily sequesters the
excess of cytosolic iron, while the L, with a more e⁄cient
iron nucleation activity, assists the H-chain in the functional-
ity of the hybrid molecules [1,15]. Thus, iron and ferritin seem
to have complex and unclear roles in apoptosis. To clarify
this, we ¢rst studied the e¡ect of iron supplementation on
tumor necrosis factor K (TNFK)-induced apoptosis in HeLa
cells, and then we analyzed whether this was attributed to the
H- or L-ferritins by using cell lines that overexpress the two
proteins. The results indicate that under these conditions iron
has an anti-apoptotic e¡ect mediated by H-ferritin upregula-
tion. Surprisingly, the e¡ect was independent from the ferrox-
idase activity of the protein, suggesting that it is not related to
the regulation of cellular iron availability. In addition, we
found that during the course of apoptosis ferritin is upregu-
lated, a possible protective response to apoptosis.
2. Materials and methods
2.1. Cells culture and induction of apoptosis
The stable clones that express ferritin H-wild type and H222 mutant
(E62K, H65G) under the control of the tetracycline promoter (named
H- and H222 clones) were described in ref. [16]. The one expressing
L-ferritin under the same promoter (L-clone) was produced as de-
scribed in ref. [16]. The cells (HeLa-TET o¡, Clontech, Palo Alto,
CA, USA) were maintained in DMEM (Life Technologies Invitrogen,
Inc., Paisley, UK, which contains 0.25 WM ferric nitrate) supple-
mented with 10% fetal bovine serum (Clontech, Palo Alto, CA), 100
mg/ml G418 (geneticin, Sigma, St. Louis, MO), 100 U/ml penicillin,
100 mg/ml streptomycin, 1 mM L-glutamin (Sigma, St. Louis, MO)
supplemented with 150 mg/ml hygromycin (Clontech, Palo Alto, CA).
To repress or induce ferritin expression the cells were grown for more
than 7 days in the presence (Dox+) or the absence (Dox3) of 2 ng/ml
doxycycline (Sigma, St. Louis, MO). Apoptosis was induced with 25
ng/ml of recombinant TNFK (kindly donated by Dr. A. Corti) and
1 Wg/ml of actinomycin D (ActD) (Sigma, St. Louis, MO).
2.2. Western blotting
The cells were suspended in lysis bu¡er (20 mM Tris^HCl, pH 8,
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200 mM LiCl, 1 mM EDTA, 0.5% NP-40) and protein concentration
was determined with the BCA assay (Pierce) calibrated on bovine
serum albumin. Samples of 20 Wg of total soluble proteins were loaded
on 12% SDS^PAGE. After transfer, the nitrocellulose ¢lters were in-
cubated with rabbit anti-PARP p85 fragment (1:500) (Promega, Mad-
ison, WI) or with mouse-anti TfR antibody (1:500) (Zymed, San
Francisco, CA) followed by secondary peroxidase-labeled antibody
(Sigma, St. Louis, MO). Bound activity was revealed by ECL (Amer-
sham, Uppsala, Sweden).
2.3. Ferritin quanti¢cation
Extracts of cells were analyzed for ferritin content by using ELISA
assays based on monoclonal antibodies speci¢c for the H-ferritin
(rH02) and the L-ferritin (L03) calibrated on the corresponding re-
combinant homopolymers expressed in Escherichia coli [16].
2.4. Nuclear fragmentation
Nuclear fragmentation was analyzed using DAPI staining: cells
(6U104) were seeded onto 24-well plates and allowed to attach for
18 h. After incubation with TNFK/ActD the cells were ¢xed in 4%
paraformaldehyde, permeabilized in 0.1% Triton X-100 and stained
with DAPI (4,6-diamidino-z-phenylindole) for 2 min [17]. The nuclei
were visualized using £uorescence microscopy.
3. Results and discussion
To set up the conditions to induce apoptosis we incubated
HeLa cells for 6 h with various concentrations of TNFK in the
presence or absence of the transcription repressor ActD which
inhibits the anti-apoptotic response elicited by the cytokine.
Cells were monitored for nuclear fragmentation using the
£uorescent dye DAPI [17], while cell viability was evaluated
by trypan blue exclusion. In the absence of ActD, the propor-
tion of apoptotic cells with fragmented nuclei was below 1%,
as expected, while it was about 34% in the presence of ActD
at TNFK concentration s 25 ng/ml (Fig. 1). Cell viability was
above 81%. Longer incubation time (18 h) in the presence of
ActD resulted in massive cell death (s 95% trypan blue pos-
itive). We chose 6 h incubation with 25 ng/ml TNFK/ActD as
suitable conditions to study apoptosis. Blotting showed that
the caspase product p85 PARP peptide [18], which was absent
in the untreated cells, accumulated after treatment (Fig. 2A).
This was accompanied by a more than two-fold decrease of
the level of transferrin receptor (TfR) (Fig. 2B). To verify
whether the TfR downregulation was related to modi¢cation
iron availability we analyzed the levels of H- and L-ferritin
types with speci¢c ELISAs. This revealed that both ferritin
types increased following the TNFK/ActD treatment (Fig.
2C). As a control, the cells were incubated for 24 h with
100 WM ferric ammonium citrate (FAC). This had no e¡ect
on p85 PARP accumulation (Fig. 2A), while downregulated
TfR (Fig. 2B) and upregulated H- and L-ferritins (Fig. 2C), as
expected. The mRNAs of H- and L-ferritins and of TfR have
iron responsive elements (IREs) necessary for a post-tran-
scriptional iron-dependent regulation mediated by the binding
activity of the iron regulatory proteins (IRPs), and therefore
the coordinate modi¢cation of these proteins during apoptosis
is very likely the response to increased iron availability [19].
Fig. 1. Apoptosis in HeLa cells induced by TNFK. The HeLa cell clone with H-ferritin cDNA under the control of Tet promoter was grown
in the presence of 2 ng/ml doxycycline to repress H-ferritin synthesis, and incubated for 6 h with various concentrations of TNFK in the pres-
ence or the absence of ActD, as indicated. The cells were harvested and stained with the £uorescent DAPI dye to evidentiate nuclear fragmen-
tation, as shown in the insert. The proportion of apoptotic cells (with fragmented nuclei) was calculated for each TNFK concentration and re-
ported in the plot. Data are representative from three independent experiments. Similar results were obtained with untransfected HeLa cells.
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However, EMSA assays did not show an evident decrease in
the IRE-binding activity of IRPs following the TNFK/ActD
treatment, while it was reduced by about 30% following iron
supplementation (not shown). To explore this further, we an-
alyzed H-ferritin and p85 PARP accumulation during the
course of the incubation with TNFK/ActD. This showed
that the caspase product became visible after 3 h incubation
and strongly increased at 5 and 6 h (Fig. 3A), while H-ferritin
level decreased in the ¢rst 2 h of incubation and then in-
creased in parallel with p85 PARP (Fig. 3B). This suggests
that in the early phase of the incubation, preceding the ap-
pearance of p85 PARP, some iron decompartmentalization
occurred which caused ferritin upregulation. This, in turn,
could sequester the excess iron and restore IRPs activity to
background level at later times, thus explaining the lack of
di¡erences observed at 6 h. It should be noticed that this
biphasic pattern of ferritin accumulation has been already
observed during post-ischemic reperfusion of rat liver, a mod-
el of oxidative damage [20], and that ferritin is induced by
H2O2 [21].
The next question was whether the changes of iron metab-
olism in response to TNFK/ActD could have an e¡ect on
apoptosis. To test this hypothesis we increased cellular iron
availability by incubating HeLa cells for 24 h with 100 WM
FAC before the treatment with TNFK/ActD. Pre-exposure to
iron reduced by about 40% the number of cells with frag-
mented nuclei and decreased by about 50% the accumulation
of p85 PARP peptide, the two indices of apoptosis used in
this work (Fig. 4A,B). To explore whether the anti-apoptotic
e¡ect caused by iron supplementation was due to increased
ferritin expression, we used the previously described HeLa
cells clones that overexpress H-ferritin wild type, the H-mu-
tant (H222) with an inactivated ferroxidase activity [16], or
L-ferritin. The cDNAs are under the control of Tet promoter
and the expression of the exogenous ferritin is induced 4^6-
fold after more than 7 days of growth in the absence of doxy-
cycline (Dox3) (Table 1). The three repressed and unre-
pressed clones were treated with TNFK/ActD, and the frac-
tion of cells with fragmented nuclei and the accumulation of
p85 PARP peptide was analyzed as above. The results showed
that the arti¢cial increase of L-ferritin had no visible e¡ect on
the two indices of apoptosis; this also indicated that the pres-
ence or absence of Dox was without e¡ect. On the other hand,
the upregulation of H-ferritin reduced both the number of
cells with fragmented nuclei and the accumulation of p85
PARP (Fig. 4C,D). Surprisingly, this occurred also with the
clone that expresses the mutant H222 with an inactivated
ferroxidase center. Iron treatment, which caused a 1.5-fold
increase in H-ferritin level reduced the two indices of apopto-
sis by less than 50%, while the 4^6-fold increase in H- and
H222 levels reduced the proportion of fragmented nuclei by
50^60% and the accumulation of p85 PARP by more than
70%.
It is known that TNFK activates anti-apoptotic transcrip-
tional responses (Fig. 1). Our data indicate that TNFK in-
duces also protective post-transcriptional responses that in-
volves H-ferritin, which is upregulated by the cytokine and
has a protective e¡ect on apoptosis. The observation that
H-ferritin induction is parallel to that of the L-ferritin and
accompanied by a downregulation of TfR suggests that it is
Fig. 2. Panel A: Cellular extracts from untreated HeLa cells (-), incubated for 24 h with 100 WM FAC or for 6 h with 25 ng/nl TNFK and
1 Wg/ml ActD (TNF/ActD) were separated on SDS^PAGE and blotted with a speci¢c antibody for the p85 peptide of PARP. Panel B: Same
as in panel A, except that anti-TfR antibody was used in blotting. Panel C: Evaluation of ferritin levels with ELISAs speci¢c for H-ferritin
(upper) and L-ferritin (lower) in the extracts of cell treated as in panel B. The data are means of three experiments and are expressed as ng of
ferritin per mg of total proteins.
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secondary to an increased iron availability, since these three
proteins are tightly controlled by the IRE/IRPs machinery
[19]. We postulate that the iron may originate from ferritin,
which is degraded in the ¢rst hours of incubation with TNFK
(Fig. 3B). Ferritin half-life in HeLa cells was found to be 12^
14 h [16], therefore the ¢nding that the amount of ferritin was
halved just 1 h after exposure to the apoptotic stimuli implies
the activation of a degradative mechanism. This was already
observed in the rat liver during post-ischemic reoxygenation
and proposed to be a consequence of the enhanced proteolytic
activity that accompanies liver oxidative damage [20].
Probably, the major ¢nding of this work was the observa-
tion that H-ferritin has an anti-apoptotic e¡ect and that this is
unrelated to its ferroxidase activity. The overexpression of
mutant H222 in HeLa cells did not a¡ect iron metabolism,
and the protein was unable to incorporate iron in vivo [16].
Therefore its anti-apoptotic activity is unrelated to modi¢ca-
tions of cellular iron availability.
Present ¢ndings are consistent with the reported cytopro-
tective activities of H-ferritin. It has been shown that the
proliferative e¡ect of c-myc requires the downregulation of
H-ferritin [22], and that hemin-induced upregulation of
H-ferritin protects cells from oxidative damage [10,11]. More
recently, it has been shown that antisense ferritin oligonucleo-
tides reduce ferritin levels in MCF-7 breast carcinoma cells
and induce apoptosis [23]. It is possible that the anti-apoptotic
activity of heme oxygenase in epithelial cells involves ferritin,
which is induced by the iron arising from heme degradation
[12,13]. In addition, we consider that the repression of ferritin
synthesis caused by iron-chelating agents may have a role in
the apoptosis they induce in HeLa cells [7^9]. Based on our
Fig. 3. Time course evaluation of p85 PARP and H-ferritin during incubation with TNFK/ActD. Panel A: Blotting analysis of p85 PARP pep-
tide on the cell extracts of the cells harvested at the time indicated. Panel B: H-ferritin concentration of the same cell extracts. The data are
means of three experiments and are expressed as ng of ferritin per mg of total proteins.
Table 1
H- and L-ferritin levels in the repressed and derepressed transfectant
clones
Cells H-ferritin
(ng/mg proteins)
L-ferritin
(ng/mg proteins)
H-clone, Dox+ 433R 79 32R 6
H-clone, Dox3 1623R 47 13R 2
L-clone, Dox+ 235R 44 25R 6
L-clone, Dox3 245R 42 161R 44
H222 clone, Dox+ 320R 16 36R 4
H222 clone, Dox3 1464R 80 8R 2
The clones were grown for more than 7 days in the presence
(Dox+) or the absence of doxycycline (Dox3) to regulate the ex-
pression of the exogenous ferritin, and the homogenates were ana-
lyzed for H-ferritin and L-ferritin content using speci¢c ELISA as-
says. Data are expressed as ng of ferritin per mg of total proteins.
Means and S.D. from at least three independent experiments. The
induced cells contain 4^6-fold more exogenous ferritin than the
non-induced ones.
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present data, we suggest that the anti-apoptotic activity of
ferritin observed in these di¡erent experimental models is un-
related to the capacity of ferritin to regulate cellular iron
availability, but rather is due to the presence of the H-ferritin
subunit ‘per se’. The substituted amino acids in the H222
variant are buried inside the subunit structure and the molec-
ular surfaces of H-wild type and mutants are probably iden-
tical, but di¡er from that of L-ferritin that has no e¡ect on
apoptotic pathways. This suggests that the H-ferritin activity
may involve a physical interaction with molecules of the ap-
optosis pathway. A physical association between H-ferritin
and Bax has been recently indicated [24], and its role needs
to be further clari¢ed.
In conclusion, the present study indicates that the apoptosis
pathways elicited by TNFK in HeLa cells involve modi¢ca-
tions of cellular iron homeostasis, and that H-ferritin partic-
ipates in the pathways independently from its ferroxidase ac-
tivity.
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